Skip to content

University Hospital Advanced Age Pregnant Cohort

University Hospital Advanced Age Pregnant Cohort

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03220750
Acronym
UNIHOPE
Enrollment
22000
Registered
2017-07-18
Start date
2017-03-28
Completion date
2020-12-31
Last updated
2017-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Spontaneous, Advanced Maternal Age Pregnancy, High Risk Pregnancy, Maternal Death, Perinatal Death, Stillbirth and Fetal Death, Various Pregnancy Complications

Brief summary

The University Hospital Advanced Age Pregnant (UNIHOPE) Cohort is the major part of the National Key Research and Development Program on Reproductive Health & Major Birth Defects Control and Prevention Project, which is funded by the Ministry of Science and Technology of China. The Project is led by Prof. Zhao Yangyu, from the Department of Gynecology & Obstetrics, Peking University Third Hospital, and the UNIHOPE cohort is led by Prof. Jian-meng Liu, the Co-PI of the Project.

Detailed description

The UNIHOPE Cohort is set up to provide comprehensive evidence for the prevention and treatment of gestational complications in pregnant women with advanced maternal age, and therefore, to meet the growing clinical challenges of increasing pregnant women with advanced age in the two-child era. The UNIHOPE Cohort is planning to recruit 22,000 pregnant women aged ≥35 years from 9 large obstetrical center of major University-affiliated Hospitals across China, between July 2016 and December 2020. All women will be enrolled prior to 14 wks of gestation, followed up at 24-28 wks, 32-34 wks of gestation, delivery, and 42 days postpartum. Data including demographics, medical history, reproductive history, prenatal health care, gestational complications, and pregnancy and birth outcomes will be collected via electronic data capture system. Venous blood of the pregnant women will be collected at enrollment and each follow-up visit during pregnancy, and placental tissue, cord blood and hair of the newborn will also be collected.

Interventions

None listed

Sponsors

Peking University Third Hospital
CollaboratorOTHER
Peking University First Hospital
CollaboratorOTHER
Obstetrics & Gynecology Hospital of Fudan University
CollaboratorOTHER
Shengjing Hospital
CollaboratorOTHER
The Third Affiliated Hospital of Guangzhou Medical University
CollaboratorOTHER
West China Second University Hospital
CollaboratorOTHER
First Affiliated Hospital of Chongqing Medical University
CollaboratorOTHER
Beijing Obstetrics and Gynecology Hospital
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
CollaboratorOTHER
Peking University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Female aged ≥ 35 years * Less than 14 gestational weeks * Planning to receive prenatal healthcare and delivery service at the study hospital

Exclusion criteria

* Inability to provide informed consent * Women with mental disorders

Design outcomes

Primary

MeasureTime frameDescription
Incidence of major gestational complications and adverse pregnancy outcomes in pregnant women with the advanced age, for a singleton or twin and higher order multiple gestationAt enrollment, 24-28 weeks, 32-34 weeks of gestation, delivery, and 42 days postpartumGestational diabetes mellitus, hypertensive disease of pregnancy, uterine scar pregnancy, placenta previa, preterm delivery, postpartum hemorrhage, low birth weight, spontaneous abortion, stillbirth, perinatal death

Secondary

MeasureTime frameDescription
Maternal deathAt 24-28 weeks, 32-34 weeks of gestation, delivery, and 42 days postpartumDeaths during pregnancy or less than 42 days after termination of pregnancy.
The rate of cesarean deliveryAt deliveryCesarean rate is defined as the number of cesarean delivery divided by the number of live births.
Gestational durationAt enrollment, deliveryThe number of weeks from the first day of the woman's last recorded menstrual period to the day of delivery deaths occurring within 28 days.
Birth weightAt deliveryEvery newborn's weight will be measured twice, but if the difference between the two measurement results is more than 0.1 kg, it will be measured for the third time, Low birth weight was defined as birth weight \<2500 g.
Birth lengthAt deliveryEvery newborn's length will be measured twice, but if the difference between the two measurement results is more than 0.1 kg, it will be measured for the third time.

Countries

China

Contacts

Primary ContactJian-meng Liu, PhD
liujm@pku.edu.cn86-10-82801136
Backup ContactHong-tian Li, PhD
liht@bjmu.edu.cn86-10-82801141

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026